ArticleBJC reports2026

Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studies.

Isaac Allen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.